Fetomaternal Adrenomedullin Levels in Diabetic Pregnancy

We investigated whether maternal and fetoplacental adrenomedullin, a newly discovered hypotensive peptide involved in the insulin regulatory system, is modified in diabetic pregnancy. We studied its correlation with pregnancy complications associated with this disease. Thirty-six pregnant women with diabetes (13 with type I and 23 with gestational diabetes mellitus) and in 40 uncomplicated pregnancies were included. 10 out of 36 diabetic pregnancies were complicated by gestational hypertension. In each woman, adrenomedullin concentration in maternal and fetal plasma and in amniotic fluid was assessed by specific radioimmunoassay. We found that overall mean amniotic fluid adrenomedullin concentration was higher (p < 0.05) in diabetic (14.7 ± 1.6 fmol/ml) than in uncomplicated pregnancies (10.8 ± 0.9 fmol/ml), whereas no differences were present in maternal and fetal plasma adrenomedullin levels between diabetic and uncomplicated pregnant women. High levels of amniotic fluid adrenomedullin were found in both type I and gestational diabetes mellitus pregnancies (13.7 ± 1.4 and 15.6 ± 2.2 fmol/ml, respectively). Diabetic pregnancies complicated by gestational hypertension showed lower (p < 0.05) amniotic fluid adrenomedullin concentrations than normotensive diabetic patients. These findings suggest that placental adrenomedullin production is upregulated in diabetic pregnancy, and it may be important to prevent excessive vasoconstriction of placental vessels.

Amniotic Fluid - Placenta - Fetus - Hypertension - Insulin - Pregnancy Complication

References

• 1 Laurini R N, Visser G HA, Ballegoodie E. Morphological feto-placental abnormalities despite well-controlled diabetic pregnancy.  Lancet. 1984;  II 800
• 2 Kitamura K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin a novel hypotensive peptide isolated from human pheochromocytoma.  Biochem Biophys Res Commun. 1993;  192 553-560
• 3 Ichiki Y, Kitamura K, Kangawa K, Kamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma.  FEBS Lett. 1994;  338 6-10
• 4 Upton P D, Austin C, Taylor G M, Nandha K A, Clark A JL, Ghatei M A, Bloom S R, Smith D M. Expression of adrenomedullin (ADM) and its binding sites in the rat uterus: increased number of binding sites and ADM messenger ribonucleic acid in 20-day pregnant rats compared with non-pregnant rats.  Endocrinology. 1997;  138 2508-2514
• 5 Hinson J P, Kapas S, Smith D M. Adrenomedullin, a multifunctional regulatory peptide.  Endocr Rev. 2000;  21 138-167
• 6 Martinez A, Weaver C, Lopez J, Bhatena S J, Elsasser T H, Miller M -J, Moody T W, Unsworth E J, Cuttitta F. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin.  Endocrinology. 1996;  137 2626-2632
• 7 Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T. Plasma adrenomedullin in diabetes.  Lancet. 1997;  350 1449-1450
• 8 Kohno N, Hanemira T, Kano H, Horio T, Yokokawa K, Ikeda M, Minami M, Yasunari K, Yoshikawa J. Plasma adrenomedullin concentrations in essential hypertension.  Hypertension. 1996;  27 102-107
• 9 Hayashi M, Shimosawa T, Fujita T. Hyperglycemia increases vascular adrenomedullin expression.  Biochem Biophys Res Commun. 1999;  258 453-456
• 10 Di lorio R, Marinoni E, Scavo D, Letizia C. Cosmi EV. Adrenomedullin in pregnancy.  Lancet. 1997;  349 328
• 11 Marinoni E, Di lorio R, Letizia C, Villaccio B, Scucchi L, Cosmi E V. Immune reactive adrenomedullin in human fetoplacental tissues.  Am J Obstet Gynecol. 1998;  179 784-787
• 12 Di lorio R, Marinoni E, Letizia C, Alò P, Villaccio B, and Cosmi E V. Adrenomedullin, a new vasoactive peptide is increased in preeclampsia.  Hypertension. 1998;  32 758-763
• 13 Di lorio R, Marinoni E, Letizia C, Gazzolo D, Lucchini C, and Cosmi E V. Adrenomedullin is increased in the feto-placental circulation in intrauterine growth retardation with abnormal umbilical artery waveforms.  Am J Obstet Gynecol. 2000;  182 650-654
• 14 Marinoni E, Di lorio R, Letizia C, Lucchini C, Alò P, and Cosmi E V. Changes in plasma adrenomedullin levels during menstrual cycle.  Regul Peptides. 2000;  87 15-18
• 15 Garcia-Unzueta M T, Montalban C, Pesquera C, Berrazueta J R, Amado J A. Plasma adrenomedullin levels in type 1 diabetes.  Diabetes Care. 1998;  21 999-1003
• 16 Nakamura T, Honda K, Ishikawa S, Kitamura K, Eto T, Saito T. Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus.  Endocr J. 1998;  45 241-246
• 17 Turk H M, Buyukberber S, Sevinc A, Ak G, Ates M, Sari R, Savli H, Cigli A. Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes.  Diabetes Care. 2000;  23 864-866
• 18 Fox H. Pathology of the placenta in maternal diabetes mellitus.  Obstet Gynecol. 1979;  34 792-798
• 19 Di lorio R, Marinoni E, Picca A, Letizia C, Anceschi M M, and Cosmi E V. Amniotic fluid endothelin-1 levels in patients with gestational diabetes mellitus.  Horm Metab Res. 1996;  28 39-40
• 20 Isumi J, Minamino N, Katafuchi T, Yoshioka M, Tsuji T, Kangawa K, Matsuo H. Adrenomedullin production in fibroblasts: its possible function as a growth regulator of Swiss 3T3 cells.  Endocrinology. 1998;  139 2552-2563
• 21 Cornish J, Gallon K E, Coy D H. Jiang NY, Xiao L, Cooper GJ, Sand Reid IR. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo.  Am J Physiol. 1997;  273 E1113-E1120